Real-time enrollment status for this diabetic macular edema clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06850922 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema |
| Phase | Clinical Trial |
| Target Enrollment | 546 participants |
| Active Locations | 63 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | February 2, 2026 (4 weeks ago) |
As of March 2, 2026: Clinical trial NCT06850922 is currently recruiting participants. This clinical trial study for diabetic macular edema is actively seeking new participants at 63 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06850922 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06850922 was last updated 4 weeks ago (February 2, 2026). HelloStudys verifies this status automatically.